Catalent Inc (CTLT)
60.75
-0.54
(-0.88%)
USD |
NYSE |
Nov 26, 16:00
60.75
0.00 (0.00%)
After-Hours: 20:00
Catalent Revenue (Annual): 4.381B for June 30, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.381B |
| June 30, 2023 | 4.263B |
| June 30, 2022 | 4.802B |
| June 30, 2021 | 3.998B |
| June 30, 2020 | 3.094B |
| June 30, 2019 | 2.518B |
| June 30, 2018 | 2.463B |
| Date | Value |
|---|---|
| June 30, 2017 | 2.075B |
| June 30, 2016 | 1.848B |
| June 30, 2015 | 1.831B |
| June 30, 2014 | 1.828B |
| June 30, 2013 | 1.800B |
| June 30, 2012 | 1.695B |
| June 30, 2011 | 1.532B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
3.094B
Minimum
2020
4.802B
Maximum
2022
4.108B
Average
4.263B
Median
2023
Revenue (Annual) Benchmarks
| Eli Lilly and Co | 34.12B |
| Boston Scientific Corp | 14.24B |
| Pfizer Inc | 58.50B |
| Merck & Co Inc | 60.12B |
| Avid Bioservices Inc | 139.91M |